Duvakitug is a monoclonal antibody commercialized by Sanofi, with a leading Phase II program in Ulcerative Colitis;Crohn's Disease (Regional Enteritis).
The sinus dilation devices market is a rapidly growing sector in the global healthcare industry. These devices are used to treat chronic sinusitis by opening up blocked sinus passageways, improving ...
Rilzabrutinib is a small molecule commercialized by Sanofi, with a leading Phase III program in Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura).